Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Identify credit cards that provide excellent rewards without any fees. Get the most out of your spending.
28,655 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Investors are eyeing a nuclear energy stock with outsized upside as regulatory momentum and a growing project pipelin...
Rhode Island unveils a sweeping rhode island housing package aimed at speeding development, loosening zoning and park...
A large insider purchase by Conagra's CEO has investors buzzing. Learn what insider buying signals really mean, how t...
A new Fed chair angles for a disciplined inflation fight and a leaner balance sheet, even as markets seek clarity. He...
A common target for retirement savings is around $1.26 million. This article breaks down what that number means in re...
Ukraine expands its drone-defense footprint in the Middle East, signaling a broader role for Kyiv as global markets w...
When the market sours, many investors reach for bonds. New research suggests this traditional playbook may need rethi...
DeCaro Auctions appoints Mario Vargas as CEO, signaling a bold push into private-client advisory services and cross-b...
A four-position, ultra-high-yield plan claims to generate over $1,000 in monthly passive income from a $100,000 start...
Three energy ETFs yielding above 2.5% are delivering 24% to 31% returns in 2026, pairing income with notable capital ...
Robotaxi headlines often focus on sensors, AI, and fleet size. The real winner may hinge on an overlooked driver. Thi...